Ionis Pharmaceuticals Inc (IONS)

Trade IONS now with
11/6/2019 7:39:25 AM Ionis Pharmaceuticals Q3 Total Revenue $168 Mln Vs. $145 Mln Last Year
9/17/2019 10:30:52 PM Antisense Announces Positive Preliminary Results From ATL1102 For DMD Phase II Trial
8/27/2019 7:05:00 AM Ionis licenses hepatitis B program to GSK (Press Release)
8/7/2019 7:09:14 AM Ionis Pharma Q2 Net Loss Attributable To Common Stockholders $1 Mln Vs. Net Loss $40 Mln Last Year
7/1/2019 7:33:05 AM Biogen Announces New Results From NURTURE Study
6/12/2019 4:16:50 PM Ionis Appoints Joan Herman To Its Board Of Directors
5/9/2019 7:15:20 AM Ionis Pharmaceuticals Q1 Net Income $84 Mln Vs. Net Loss $1 Mln Last Year
3/25/2019 7:06:17 AM Ionis Names Brett Monia To Board
2/27/2019 7:04:13 AM Ionis Pharma Q4 Net Income $320 Mln Or $2.21/shr Vs. Net Loss $2.9 Mln Or $0.03/shr Last Year
12/6/2018 7:31:47 AM Biogen Exercises Option To Obtain From Ionis License To Develop And Commercialize BIIB067
11/29/2018 7:09:21 AM Akcea Therapeutics To Present Long-term Analyses Of NEURO-TTR Open-label Extension Study At ASH Annual Meeting
11/12/2018 6:57:41 AM Akcea : Phase 2 Results On AKCEA-APO-LRx Presented In Late-Breaking Clinical Trial Presentation
11/6/2018 7:19:14 AM Ionis Pharma Q3 Net Loss $5 Mln Vs. Net Loss $3 Mln Last Year
11/5/2018 4:12:13 PM Akcea Therapeutics Q3 EPS $0.73 Vs. Loss $0.33 Year Ago
10/10/2018 9:08:09 AM Ionis Announces New Collaboration With Roche To Develop IONIS-FB-LRx For Treatment Of Complement-mediated Diseases
10/8/2018 7:02:56 AM Akcea Therapeutics: Damien McDevitt Replaces Stanley Crooke On Board